DANIEL MCRORY: Open Payments
NPI 1972138675 · HOWELL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 11 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $137 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Pulmonx Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
Products named: ZERBAXA, ARALAST, EMBLAVEO, CHARTIS CATHETER, JARDIANCE, CLEVIPREX, Rezzayo.
Industry payments across NJ — which companies pay providers there.
